Liang Y, Xie S, Zheng X, Wu X, Du S, Jiang Y
J Transl Med. 2024; 22(1):1144.
PMID: 39719617
PMC: 11668030.
DOI: 10.1186/s12967-024-05982-2.
Zhu W, Tang X, Chen Y, Chen M, Han X, Xie Y
Epidemiol Infect. 2024; 152:e144.
PMID: 39552127
PMC: 11574606.
DOI: 10.1017/S0950268824001274.
Beishuizen B, Stein M, Buis J, Tostmann A, Green C, Duggan J
BMC Public Health. 2024; 24(1):3114.
PMID: 39529010
PMC: 11552315.
DOI: 10.1186/s12889-024-20629-z.
Hadley E, Yoo Y, Patel S, Zhou A, Laraway B, Wong R
Commun Med (Lond). 2024; 4(1):129.
PMID: 38992084
PMC: 11239932.
DOI: 10.1038/s43856-024-00539-2.
Shen H, Chen D, Li C, Huang T, Ma W
Health Sci Rep. 2024; 7(4):e2016.
PMID: 38605725
PMC: 11007061.
DOI: 10.1002/hsr2.2016.
Long-term outcomes of hospitalized patients with SARS-CoV-2/COVID-19 with and without neurological involvement: 3-year follow-up assessment.
Eligulashvili A, Gordon M, Lee J, Lee J, Mehrotra-Varma S, Mehrotra-Varma J
PLoS Med. 2024; 21(4):e1004263.
PMID: 38573873
PMC: 10994395.
DOI: 10.1371/journal.pmed.1004263.
COVID-19 reinfections in Mexico City: implications for public health.
Anda-Jauregui G, Gomez-Romero L, Canas S, Campos-Romero A, Alcantar-Fernandez J, Cedro-Tanda A
Front Public Health. 2024; 11:1321283.
PMID: 38419814
PMC: 10899476.
DOI: 10.3389/fpubh.2023.1321283.
SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020-2022.
Teran R, Gagner A, Gretsch S, Lauritsen J, Galanto D, Walblay K
Emerg Infect Dis. 2023; 29(11):2257-2265.
PMID: 37877555
PMC: 10617359.
DOI: 10.3201/eid2911.230577.
Longitudinal study of humoral immunity against SARS-CoV-2 of health professionals in Brazil: the impact of booster dose and reinfection on antibody dynamics.
Franco-Luiz A, Fernandes N, de Souza Silva T, Bernardes W, Westin M, Santos T
Front Immunol. 2023; 14:1220600.
PMID: 37520570
PMC: 10376701.
DOI: 10.3389/fimmu.2023.1220600.
An ecological study on reinfection rates using a large dataset of RT-qPCR tests for SARS-CoV-2 in Santiago of Chile.
Acuna-Castillo C, Barrera-Avalos C, Bachelet V, Milla L, Inostroza-Molina A, Vidal M
Front Public Health. 2023; 11:1191377.
PMID: 37492136
PMC: 10364051.
DOI: 10.3389/fpubh.2023.1191377.
Increased Hospitalizations Involving Fungal Infections during COVID-19 Pandemic, United States, January 2020-December 2021.
Gold J, Adjei S, Gundlapalli A, Huang Y, Chiller T, Benedict K
Emerg Infect Dis. 2023; 29(7):1433-1437.
PMID: 37347805
PMC: 10310397.
DOI: 10.3201/eid2907.221771.
Global prevalence of coronavirus disease 2019 reinfection: a systematic review and meta-analysis.
Ukwishaka J, Ndayishimiye Y, Destine E, Danwang C, Kirakoya-Samadoulougou F
BMC Public Health. 2023; 23(1):778.
PMID: 37118717
PMC: 10140730.
DOI: 10.1186/s12889-023-15626-7.
SARS-CoV-2 Reinfection is Preceded by Unique Biomarkers and Related to Initial Infection Timing and Severity: an N3C RECOVER EHR-Based Cohort Study.
Hadley E, Yoo Y, Patel S, Zhou A, Laraway B, Wong R
medRxiv. 2023; .
PMID: 36656776
PMC: 9844020.
DOI: 10.1101/2023.01.03.22284042.
Current and Emerging Knowledge in COVID-19.
Jeong Y, Wi Y, Park H, Lee J, Kim S, Lee K
Radiology. 2023; 306(2):e222462.
PMID: 36625747
PMC: 9846833.
DOI: 10.1148/radiol.222462.
Smoking cessation in the elderly as a sign of susceptibility to symptomatic COVID-19 reinfection in the United States.
Ando W, Horii T, Jimbo M, Uematsu T, Atsuda K, Hanaki H
Front Public Health. 2022; 10:985494.
PMID: 36504971
PMC: 9733529.
DOI: 10.3389/fpubh.2022.985494.
Reinfection with SARS-CoV-2 in a patient undergoing chemotherapy for lymphoma: Case report.
Cote F, Bestman-Smith J, Gourdeau M, Simpson S, Hamelin M, Carbonneau J
J Assoc Med Microbiol Infect Dis Can. 2022; 7(3):283-291.
PMID: 36337604
PMC: 9629731.
DOI: 10.3138/jammi-2021-0036.
Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England.
Strasser Z, Greifer N, Hadavand A, Murphy S, Estiri H
JAMA Netw Open. 2022; 5(10):e2238354.
PMID: 36282501
PMC: 9597387.
DOI: 10.1001/jamanetworkopen.2022.38354.
Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study.
Turbett S, Tomkins-Tinch C, Anahtar M, Dugdale C, Hyle E, Shenoy E
Clin Infect Dis. 2022; 76(5):850-860.
PMID: 36268576
PMC: 9619827.
DOI: 10.1093/cid/ciac830.
SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria.
Marinov G, Mladenov M, Rangachev A, Alexiev I
PLoS One. 2022; 17(9):e0274509.
PMID: 36084070
PMC: 9462809.
DOI: 10.1371/journal.pone.0274509.
Epidemiological and clinical characteristics of SARS-CoV-2 reinfections in a Spanish region.
Yuguero O, Companys M, Guzman M, Maciel R, Llobet C, Lopez A
SAGE Open Med. 2022; 10:20503121221108556.
PMID: 35784672
PMC: 9244920.
DOI: 10.1177/20503121221108556.